#Australia #LabConnect #Clinical Trials #ACL Specialised Trials #Port Melbourne

Strategic Partnership to Boost Clinical Trials in Australia

LabConnect and Australian Clinical Labs' (ACL) Specialized Trials have entered into a strategic partnership aimed at expanding clinical trial support across Australia and the Asia-Pacific region. This long-term agreement allows both organizations to leverage their complementary strengths to enhance access to essential medications for patients, responding to an increasing regional demand for clinical trial support services from pharmaceutical and biotechnology companies, as well as clinical research organizations.

ACL Specialized Trials is recognized as one of Australia’s leading clinical trial laboratories. The company adeptly manages large-scale biotechnology and pharmaceutical clinical trials, spanning phases 1 through 4. With an extensive network of laboratories throughout Australia, ACL Specialized Trials has substantial experience in delivering end-to-end pathology solutions and a comprehensive array of central laboratory services for both national and multi-site clinical studies.

Melinda McGrath, the CEO of ACL Group, emphasized the significance of this partnership, stating, “This long-term collaboration will assist international clients in accessing Australian patients and introduce crucial international trials to this part of the world. Ultimately, this partnership aims to advance groundbreaking medical discoveries that can save lives and improve patient outcomes.” She further mentioned how this partnership will solidify their position in a burgeoning $8 billion market and expressed excitement about showcasing their deep expertise and talented team on a global scale.

As the world’s most agile central laboratory solutions partner, LabConnect will utilize ACL's extensive trial portfolio, offering a comprehensive suite of services to support the region. This includes the construction of in-country laboratory kits, biological sample management, project and data management, as well as logistical support.

Catherine Osborne, the General Manager for APAC at LabConnect, will oversee operational activities within the region. As the leading laboratory service provider for LabConnect in Australia and APAC, ACL Specialized Trials will support LabConnect with its dedicated clinical trial laboratory and project team located in Port Melbourne, Victoria, which will serve as the operational hub for the area.

Wes Wheeler, CEO of LabConnect, noted that “An increasing number of our clients are incorporating regional sites in their clinical development strategies. Our partnership with ACL Specialized Trials provides us with a platform from which we can deliver our comprehensive central laboratory services throughout the region.”

About ACL Specialized Trials

ACL Specialized Trials is a subsidiary of Australian Clinical Labs, embodying their commitment to improving patient lives through medical excellence, state-of-the-art technology, and a talented team of experts. Specializing in providing dedicated pathology services for phase I-IV clinical trials, ACL Specialized Trials delivers quality solutions to its clients. Their purpose-built, cutting-edge facilities and years of commercial and clinical trial experience ensure a smooth transition from initial demand to delivery.

For more information, visit specialisedtrials.com.au
Follow them on LinkedIn.

About LabConnect

LabConnect is recognized as the world’s most agile central laboratory solutions partner, providing tailored, orchestrated, and scalable support services focused on technology for clinical trials of all sizes and complexities. With over 20 years of experience and more than 1,900 clinical studies across 93 countries, LabConnect is a trusted partner for biotechnology, pharmaceutical, and clinical research organizations.

LabConnect is well-positioned to facilitate access to cutting-edge innovations and automation through modern operations and strategic partnerships with renowned laboratories. They offer exceptional service through a comprehensive range of central laboratory solutions, including custom laboratory kits, advanced sample tracking, integrated logistics, standardized sample processing globally, a leading-edge testing menu featuring over 10,200 validated assays, global support for radiopharmaceutical products, and next-generation biobanking.

LabConnect’s scientific experts support preclinical and clinical studies through project management, biological and bioanalytical sample handling, biomarker strategy, and logistical solutions. The company excels in data management, integrating complex datasets from various sources into coherent, submission-ready datasets.

Follow LabConnect on LinkedIn for updates and insights into clinical trials.
To learn more, visit labconnect.com.